Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

BioScience Health Innovations (BHIC) Intangibles (2024 - 2026)

BioScience Health Innovations has reported Intangibles over the past 3 years, most recently at $82887.0 for Q1 2026.

  • Quarterly Intangibles rose 47.91% to $82887.0 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $82887.0 through Mar 2026, up 47.91% year-over-year, with the annual reading at $82887.0 for FY2025, 218.34% up from the prior year.
  • Intangibles was $82887.0 for Q1 2026 at BioScience Health Innovations, roughly flat from $82887.0 in the prior quarter.
  • Over five years, Intangibles peaked at $82887.0 in Q4 2025 and troughed at $7037.0 in Q3 2024.
  • The 3-year median for Intangibles is $72101.0 (2025), against an average of $57012.4.
  • Year-over-year, Intangibles soared 924.6% in 2025 and then skyrocketed 47.91% in 2026.
  • A 3-year view of Intangibles shows it stood at $26037.0 in 2024, then surged by 218.34% to $82887.0 in 2025, then changed by 0.0% to $82887.0 in 2026.
  • Per Business Quant, the three most recent readings for BHIC's Intangibles are $82887.0 (Q1 2026), $82887.0 (Q4 2025), and $72101.0 (Q3 2025).